Kenneth Bahrt, SVP, Chief Medical Officer at SAVIENT PHARMACEUTICALS INC (SVNT), sold 29,000 shares at $1.01 ($30K) on 2013-02-04, disclosed to the SEC on 2013-02-06.
Scheduled sale ($30k) by SVP, Chief Medical Officer under a pre-arranged 10b5-1 plan. Pre-set trade — not a discretionary signal on the stock.
Nothing distinguishes this filing.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $1.01 | 7,300 | $7K | 24.6% |
| 2 | $1.04 | 21,700 | $23K | 75.4% |
| Total | $1.03 avg | 29,000 | $30K | 100% |
| Filing → |
| SVNT | SELL | 2013-10-17 | $6K | — | Filing → |
| SVNT | SELL | 2013-05-01 | $925 | — | Filing → |
| SVNT | SELL | 2013-02-04 | $1K | — | Filing → |